pfizer biontech bnt16b2b2 Search Results


90
BioNTech pfizer biontech bnt16b2b2
(A) A case of a 17‐year‐old female with IgA‐vasculitis 10 days after the first dose of Pfizer‐BioNTech <t>BNT16B2b2</t> mRNA vaccine. (B) A case of 48‐year‐old man with LCV 4 days after the second dose of Pfizer‐BioNTech BNT16B2b2 mRNA vaccine
Pfizer Biontech Bnt16b2b2, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+biontech+bnt16b2b2/pfizer+biontech+bnt16b2b2/pmc09111803-17-33-32
Average 90 stars, based on 1 article reviews
pfizer biontech bnt16b2b2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


(A) A case of a 17‐year‐old female with IgA‐vasculitis 10 days after the first dose of Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. (B) A case of 48‐year‐old man with LCV 4 days after the second dose of Pfizer‐BioNTech BNT16B2b2 mRNA vaccine

Journal: Dermatologic Therapy

Article Title: SARS‐CoV‐2 vaccination‐induced cutaneous vasculitis: Report of two new cases and literature review

doi: 10.1111/dth.15458

Figure Lengend Snippet: (A) A case of a 17‐year‐old female with IgA‐vasculitis 10 days after the first dose of Pfizer‐BioNTech BNT16B2b2 mRNA vaccine. (B) A case of 48‐year‐old man with LCV 4 days after the second dose of Pfizer‐BioNTech BNT16B2b2 mRNA vaccine

Article Snippet: Nastroet al., 2021 , 84/M , Palpable purpura on the legs , Leukocytoclastic vasculitis , 2 days , 2 weeks , First dose , Recovery , Systemic antihistamine and local steroid , Pfizer‐BioNTech BNT16B2b2.

Techniques:

Cutaneous vasculitis reports related to SARS‐CoV‐2 vaccine in the literature, and two new cases

Journal: Dermatologic Therapy

Article Title: SARS‐CoV‐2 vaccination‐induced cutaneous vasculitis: Report of two new cases and literature review

doi: 10.1111/dth.15458

Figure Lengend Snippet: Cutaneous vasculitis reports related to SARS‐CoV‐2 vaccine in the literature, and two new cases

Article Snippet: Nastroet al., 2021 , 84/M , Palpable purpura on the legs , Leukocytoclastic vasculitis , 2 days , 2 weeks , First dose , Recovery , Systemic antihistamine and local steroid , Pfizer‐BioNTech BNT16B2b2.

Techniques: Histopathology